Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-02-18

FDA Approved: DROXIDOPA — Original Application (CivicaScript LLC)

View source ↗

Summary

FDA approved the original application for droxidopa (generic) by CivicaScript LLC to treat neurogenic orthostatic hypotension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Droxidopa (Droxidopa)

Snippet

ORIG AP for DROXIDOPA (DROXIDOPA)